THTX•benzinga•
The FDA Approved Theratechnologies' Prior Approval Supplement To The Supplemental Biologics License Application For Egrifta SV (Tesamorelin For Injection). Tesamorelin For Injection Is Approved In The Us To Reduce Excess Abdominal Fat In Adults With HIV A
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on April 8, 2025 by benzinga